Renal Cancer

New Mediastinal and Hilar Lymphadenopathy After Adjuvant Pembrolizumab in a Patient With Stage III Clear Cell Renal Cell Carcinoma. February 6, 2025

Diagnostic performance of artificial intelligence in detection of renal cell carcinoma: a systematic review and meta-analysis. February 6, 2025

MAPK1IP1L::TFE3-rearranged renal cell carcinoma: a novel fusion adding to the differential diagnosis of oncocytic renal neoplasms. February 6, 2025

Multi-institutional Analysis of Immune-Oncology Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma. February 5, 2025

Surgical options for advanced renal cell carcinoma. February 5, 2025

Multicenter study of active surveillance for small renal masses: Real world practice pattern. February 5, 2025

Trend of cardiovascular mortality among metastatic renal cell cancer patients in the US from 2005 to 2020. February 4, 2025

Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study. February 4, 2025

Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear Cell Renal Cell Carcinoma. February 3, 2025

Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial. February 3, 2025

Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers. January 31, 2025

Recurrence after surgery for clear cell and papillary renal cell carcinoma: Head-to head comparison of validated risk scores. January 31, 2025

Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3). January 30, 2025

Deciphering the interplay between SETD2 mediated H3K36me3 and RNA N6-methyladenosine in clear cell renal cell carcinoma (ccRCC). January 30, 2025

Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinations. January 29, 2025

Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study. January 29, 2025

A Review of Neoadjuvant Therapy for Localized and Locally Advanced Renal Cell Carcinoma. January 28, 2025

Endovascular Downstaging: A New Method for Managing Renal Cell Carcinoma Tumor Thrombus Invading the Inferior Vena Cava Above the Hepatic Veins (Level III) or into the Heart (Level IV). January 28, 2025

A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types. January 27, 2025

Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort study. January 27, 2025

Page 1 of 460